
Results
7
Well rounded companies, with acceptable leverage, projected to deliver an ROE north of 20% in three years.
7 companies
AstraZeneca
Market Cap: UK£186.9b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZN
UK£120.50
7D
3.0%
1Y
0.6%
Chugai Pharmaceutical
Market Cap: JP¥11.3t
Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.
4519
JP¥7,066.00
7D
-1.5%
1Y
12.2%
Orion Oyj
Market Cap: €11.1b
Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.
ORNBV
€79.10
7D
1.5%
1Y
13.6%
Shanghai Allist Pharmaceuticals
Market Cap: CN¥52.4b
A pharmaceutical company, engages in the research and development of tumor-targeted drugs in China in internationally.
688578
CN¥116.48
7D
-0.7%
1Y
29.0%
Xiamen Amoytop Biotech
Market Cap: CN¥26.3b
Engages in research, development, production, and sale of recombinant protein drugs in China and internationally.
688278
CN¥64.40
7D
8.5%
1Y
-25.0%
Laboratorios Farmaceuticos Rovi
Market Cap: €3.1b
Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.
ROVI
€59.70
7D
3.3%
1Y
4.1%
PharmaResearch
Market Cap: ₩4.1t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩391,000.00
7D
-4.2%
1Y
-40.1%